Vivante Health is excited to announce that it has successfully raised $31 million in its latest funding round, a significant milestone that underscores the growing demand for innovative healthcare solutions. As a leader in personalized, clinician-backed care for a comprehensive range of digestive issues, Vivante Health is dedicated to transforming the way digestive health is managed by harnessing the power of advanced technology. Our virtual health platform, delivered as an employer-sponsored benefit, provides employees with tailored support and resources to better understand and manage their digestive health. The funds raised will be instrumental in enhancing our platform's capabilities, allowing us to expand our reach and improve access to essential care for individuals experiencing digestive challenges. This new capital will also facilitate the development of additional features and services that empower users to engage with their health more proactively. With a mission to break down barriers to digestive health care, Vivante Health aims to provide individuals with the tools they need to lead healthier lives. By collaborating closely with employers to offer our virtual health services, we are setting the stage for a revolutionary approach to workplace wellness that prioritizes holistic well-being. As we move forward, we are eager to deepen our impact on healthcare accessibility and improve the quality of life for countless individuals navigating complex digestive issues. Our commitment to innovation and patient-centric care remains steadfast, and this funding marks an exciting new chapter for Vivante Health.
Vivante Health Secures $31 Million in Series B Funding for Innovative Digestive Health Platform
Recently funded · $31.0M Series bHospitals and Health Care
Get the full Vivante Health company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
